Completed Clinical 1993

    Regulation of growth hormone secretion by growth hormone-releasing peptide-6 (GHRP-6)

    Micic D, Popovic V, Doknic M, et al.

    Journal of Pediatric Endocrinology

    Summary

    Early clinical characterization of GHRP-6 as a potent growth hormone secretagogue in humans. Demonstrated that GHRP-6 stimulates GH release through a mechanism distinct from GHRH, and that combined administration produces synergistic GH responses.

    Key Findings

    • GHRP-6 potently stimulated GH release in human subjects
    • Mechanism of action distinct from growth hormone-releasing hormone (GHRH)
    • Synergistic GH response observed when GHRP-6 combined with GHRH

    Related Monographs

    Related Studies

    View all →
    Completed 2013

    Pharmacokinetic study of growth hormone-releasing peptide 6 (GHRP-6) in rats

    Cabrales A, Gil J, Fernández E, et al.

    European Journal of Pharmaceutical Sciences

    Comprehensive pharmacokinetic characterization of GHRP-6 in rats following intravenous and subcutaneous administration. Established bioavailability parameters, distribution, and elimination kinetics essential for dosing protocol development.

    • Characterized absorption, distribution, and elimination kinetics of GHRP-6
    • Established subcutaneous bioavailability parameters for dosing optimization

    DOI: 10.1016/j.ejps.2012.10.006

    Completed 2006

    Use of growth hormone-releasing peptide 6 (GHRP-6) for the prevention of multiple organ failure

    Cibrián D, Ajamieh H, Berlanga J, et al.

    Clinical Science

    Demonstrated that GHRP-6 administration prevented multiple organ failure in a liver ischemia-reperfusion injury model. The cytoprotective effects were mediated through anti-inflammatory and antioxidant mechanisms independent of growth hormone release.

    • GHRP-6 prevented multiple organ failure following hepatic ischemia-reperfusion injury
    • Cytoprotective effects were independent of GH secretion

    DOI: 10.1042/CS20050374